Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMC Neurology|January 3, 2025
Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysisDaiki Tokuyasu, Shungo Imai, Shih-Pin Chen, et al.
Cephalalgia : an International Journal of Headache|December 17, 2025
Estrogen exposure from modern contraceptives and vascular risk in women with migraine: A nationwide electronic medical record database studyKeiko Ihara, C William Pike, Gavin Hui, et al.
BMC Neurology|November 14, 2023
Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective studySeiya Ohtani, Narumi Watanabe, Keiko Ihara, et al.
Internal Medicine (Tokyo, Japan)|August 13, 2025
Effect of Galcanezumab on PHQ-9 and GAD-7 in Patients with Migraine: A Real-world Study in JapanKota Oshima, Yuna Hattori, Keiko Ihara, et al.
The Journal of Headache and Pain|March 8, 2023
Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational studyKeiko Ihara, Seiya Ohtani, Narumi Watanabe, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 5, 2023
Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative reviewTsubasa Takizawa, Keiko Ihara, Shunsuke Uno, et al.
Journal of the Neurological Sciences|January 15, 2026
A 12-month observational study on the safety, efficacy on migraine-associated symptoms and satisfaction of CGRP monoclonal antibodies in Japanese patients with migraineShungo Imai, Keiko Ihara, Nobuyuki Takahashi, et al.
Nature Communications|April 27, 2023
Mesolimbic dopamine release precedes actively sought aversive stimuli in miceYosuke Yawata, Yu Shikano, Jun Ogasawara, et al.
The Journal of Headache and Pain|March 16, 2024
CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache societyTsubasa Takizawa, Keiko Ihara, Narumi Watanabe, et al.
Internal Medicine (Tokyo, Japan)|August 7, 2024
Real-world Efficacy of Erenumab on Migraine-associated Symptoms and Patient-reported Satisfaction Levels: A Retrospective Study in JapanKeiko Ihara, Nobuyuki Takahashi, Seiya Ohtani, et al.
Pageof 3